Home › Chronic Progressive Multiple Sclerosis › Massachusetts
Chronic Progressive Multiple Sclerosis clinical trials in Massachusetts
3 studies for Chronic Progressive Multiple Sclerosis are looking for participants at sites in Massachusetts.
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- University of Massachusetts Memorial Medical Center, Worcester
RecruitingPhase 3
Ages 18 to 60 · All sexes · Updated Nov 12, 2026 · NCT07299019Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Massachusetts Memorial Medical Center, Worcester
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Oct 20, 2026 · NCT04047628A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Neuro Institute of New England P C, Foxborough
- Elliot Lewis MS Center, Wellesley
- U Mass Memorial Medical Center, Worchester
RecruitingPhase 3
Ages 18 to 65 · All sexes · Updated Oct 13, 2026 · NCT07225504From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.